Infinity Pharmaceuticals reported $-14127000 in Equity Capital and Reserves for its third fiscal quarter of 2020.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Equity Capital And Reserves Change
Abbvie ABBV:US $ 13076M 2194M
Amgen AMGN:US $ 9409M 1550M
AstraZeneca AZN:LN 15622M 3427M
Bristol Myers Squibb BMY:US $ 37822M 12336M
Cytori Therapeutics CYTX:US $ 3.03M 0.41M
Eisai 4523:JP Y 672178M 6026M
Eli Lilly And LLY:US $ 5641.6M 814.7M
Genocea Biosciences GNCA:US $ 8.98M 11.22M
Gilead Sciences GILD:US $ 18202M 757M
GlaxoSmithKline GSK:LN 14587M 301M
Johnson & Johnson JNJ:US $ 63278M 1195M
Mirati Therapeutics MRTX:US $ 1360.79M 809.85M
Novartis NOVN:VX SF 56598M 2114M
Pfizer PFE:US $ 63238M 2021M
Seattle Genetics SGEN:US $ 3488.1M 1230.07M
YTE INCY:US $ 2611.27M 220.44M